Jason S Lewis Selected Research

Androgens

11/2016	Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis.
11/2015	Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.
5/2013	Antilipolytic drug boosts glucose metabolism in prostate cancer.
1/2013	Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
5/2009	Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.
9/2005	Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jason S Lewis Research Topics

Disease

185	Neoplasms (Cancer) 05/2024 - 01/2002
34	Breast Neoplasms (Breast Cancer) 01/2024 - 07/2005
32	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 09/2005
20	Hypoxia (Hypoxemia) 06/2020 - 03/2002
14	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2009
13	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 12/2015
9	Colorectal Neoplasms (Colorectal Cancer) 11/2020 - 08/2013
8	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 08/2013
8	Adenocarcinoma 11/2023 - 11/2013
7	Glioma (Gliomas) 01/2021 - 02/2007
6	Stomach Neoplasms (Stomach Cancer) 10/2023 - 06/2013
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2020 - 03/2013
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 01/2017
4	Lymphoma (Lymphomas) 06/2023 - 02/2016
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2013
4	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2013
4	Carcinoma (Carcinomatosis) 10/2018 - 02/2008
4	Melanoma (Melanoma, Malignant) 05/2009 - 04/2005
3	Acidosis 01/2022 - 01/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2008 - 04/2003
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

33	AntigensIBA 05/2024 - 10/2011
26	Biomarkers (Surrogate Marker)IBA 03/2024 - 02/2008
25	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 08/2013
21	AntibodiesIBA 05/2024 - 08/2013
19	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2005
18	Radioisotopes (Radionuclides)IBA 01/2024 - 07/2002
16	Trastuzumab (Herceptin)FDA Link 01/2024 - 01/2010
16	human ERBB2 proteinIBA 01/2024 - 06/2013
14	RadiopharmaceuticalsIBA 05/2024 - 12/2006
12	ErbB Receptors (EGF Receptor)IBA 01/2024 - 06/2013
11	Monoclonal AntibodiesIBA 01/2024 - 03/2009
11	LigandsIBA 01/2024 - 03/2002
11	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 04/2012
11	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 02/2010 - 11/2002
10	Peptides (Polypeptides)IBA 05/2024 - 04/2005
9	CopperIBA 01/2023 - 03/2002
8	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023 - 07/2002
8	Chelating AgentsIBA 01/2020 - 07/2002
6	zirconium-89-trastuzumabIBA 01/2023 - 06/2013
6	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2020 - 07/2002
6	Glucose (Dextrose)FDA LinkGeneric 03/2020 - 09/2003
6	AndrogensIBA 11/2016 - 09/2005
5	Pentetic Acid (DTPA)FDA LinkGeneric 03/2024 - 07/2002
5	GoldIBA 01/2024 - 01/2019
5	Lovastatin (Mevacor)FDA LinkGeneric 10/2023 - 12/2018
5	Immunoglobulin G (IgG)IBA 01/2022 - 03/2009
5	procaine isothiocyanate (PRIT)IBA 01/2020 - 01/2017
4	Zirconium-89IBA 01/2024 - 01/2016
4	Deferoxamine (Desferal)FDA LinkGeneric 01/2024 - 10/2010
4	CholesterolIBA 01/2023 - 01/2016
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 06/2013
4	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 01/2016
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
4	Liposomes (Liposome)IBA 01/2021 - 03/2013
4	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 10/2020 - 01/2010
4	CarbohydratesIBA 10/2020 - 03/2016
4	fluoromisonidazoleIBA 06/2020 - 04/2005
4	AcidsIBA 05/2020 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 05/2009
4	alpha-MSHIBA 05/2009 - 04/2005
3	pertuzumabIBA 01/2024 - 11/2019
3	MetalsIBA 12/2023 - 07/2002
3	Caveolin 1IBA 10/2023 - 12/2018
3	pHLIP proteinIBA 10/2023 - 05/2009
3	ZirconiumIBA 01/2023 - 01/2020
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 12/2020
3	omburtamab I-131IBA 11/2022 - 12/2019
3	Panitumumab (Vectibix)FDA Link 01/2022 - 12/2020
3	Cetuximab (Erbitux)FDA Link 01/2021 - 03/2014
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2021 - 03/2014
3	PolymersIBA 06/2020 - 01/2018
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2019 - 07/2002
3	Hormones (Hormone)IBA 01/2019 - 01/2013
3	Transferrin (beta 2 Transferrin)IBA 01/2018 - 01/2013
3	Immunoglobulin FragmentsIBA 07/2017 - 03/2009
3	Estrogen ReceptorsIBA 04/2015 - 05/2009
3	Deoxyglucose (2 Deoxy D glucose)IBA 08/2014 - 09/2003
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2013 - 02/2008
3	ThiosemicarbazonesIBA 12/2006 - 03/2002
2	PSMA-617IBA 04/2024 - 01/2022
2	MucinsIBA 03/2024 - 03/2022
2	Polysaccharides (Glycans)IBA 03/2024 - 01/2016
2	Lysine (L-Lysine)FDA Link 01/2024 - 11/2007
2	trastuzumab deruxtecanIBA 10/2023 - 01/2020
2	Ado-Trastuzumab EmtansineIBA 10/2023 - 01/2020
2	IodineIBA 01/2023 - 07/2002
2	FluorineIBA 01/2023 - 01/2018
2	IsotopesIBA 01/2023 - 10/2003
2	N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA 01/2022 - 05/2009
2	Immune Checkpoint InhibitorsIBA 12/2021 - 10/2021

Therapy/Procedure

79	Therapeutics 05/2024 - 01/2002
22	Radiotherapy 10/2021 - 04/2003
13	Radioimmunotherapy 11/2022 - 10/2010
12	Drug Therapy (Chemotherapy) 10/2023 - 04/2003
9	Castration 01/2023 - 04/2012
8	Precision Medicine 04/2024 - 11/2019
3	Ligation 01/2019 - 02/2015
2	Operative Surgical Procedures 04/2024 - 06/2011
2	Intravenous Administration 12/2023 - 08/2015